InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,442.87
(
-0.06%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TraderUsa

Send PM Follow Ignore
Followers 79
Posts 7854
Boards Moderated 2
Alias Born 05/05/2011

TraderUsa

Re: None

Wednesday, 10/25/2017 4:55:17 PM

Wednesday, October 25, 2017 4:55:17 PM

Post# of 2804248
$ATOS (Atossa Genetics) have a Market Cap only $10MM.

Learn CLDX example in this article. Phase II for breast cancer have Market Target: $5 Billion sales, and valuation with Market Cap of CLDX is $448MM. The valuation said that strong undervalued.

$$$$$$$$$$$$$$$$$$$$$$$$$$$

https://www.fool.com/investing/2016/12/19/how-to-value-clinical-stage-biotech-stocks.aspx

Is my humble opinion.

Do not forget to go through this ihub :
http://investorshub.advfn.com/boards/board.aspx?board_id=20991

Gainers Nasdaq Stocks Traders

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up